Hereditary breast and ovarian cancer

被引：0

作者：

Jacek Gronwald

Tomasz Byrski

Tomasz Huzarski

Oleg Oszurek

Anna Janicka

Jolanta Szymańska-Pasternak

Bohdan Górski

Janusz Menkiszak

Izabella Rzepka-Górska

Jan Lubiński

机构：

[1] Pomeranian Medical University,International Hereditary Cancer Centre, Department of Genetics and Pathology

[2] Pomeranian Medical University,Department of Surgical Gynaecology and Gynaecological Oncology of Adults and Adolescents

[3] Pomeranian Medical University,International Hereditary Cancer Centre, Department of Genetics and Pathology

来源：

Hereditary Cancer in Clinical Practice | / 6卷

关键词：

Breast Cancer; Ovarian Cancer; Tamoxifen; Breast Cancer Risk; BRCA2 Mutation;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[31] Surveillance behavior and prophylactic surgery after predictive testing for hereditary breast/ovarian cancer
Claes, E
Evers-Kiebooms, G
Decruyenaere, M
Denayer, L
Boogaerts, A
Philippe, K
Legius, E
BEHAVIORAL MEDICINE, 2005, 31 (03) : 93 - 105
[32] The French Genetic and Cancer Consortium guidelines for multigene panel analysis in hereditary breast and ovarian cancer predisposition
Moretta, Jessica
Berthet, Pascaline
Bonadona, Valerie
Caron, Olivier
Cohen-Haguenauer, Odile
Colas, Chrystelle
Corsini, Carole
Cusin, Veronica
De Pauw, Antoine
Delnatte, Capucine
Dussart, Sophie
Jamain, Christophe
Longy, Michel
Luporsi, Elisabeth
Maugard, Christine
Tan Dat Nguyen
Pujol, Pascal
Vaur, Dominique
Andrieu, Nadine
Lasset, Christine
Nogues, Catherine
BULLETIN DU CANCER, 2018, 105 (10) : 907 - 917
[33] Exon splicing analysis of intronic variants in multigene cancer panel testing for hereditary breast/ovarian cancer
Ryu, Jin-Sun
Lee, Hye-Young
Cho, Eun Hae
Yoon, Kyong-Ah
Kim, Min-Kyeong
Joo, Jungnam
Lee, Eun-Sook
Kang, Han-Sung
Lee, Seeyoun
Lee, Dong Ock
Lim, Myong Cheol
Kong, Sun-Young
CANCER SCIENCE, 2020, 111 (10) : 3912 - 3925
[34] Is low-grade serous ovarian cancer part of the tumor spectrum of Hereditary Breast and Ovarian Cancer?
Vineyard, Marisa A.
Daniels, Molly S.
Urbauer, Diana L.
Deavers, Michael T.
Sun, Charlotte C.
Boerwinkle, Eric
Bodurka, Diane C.
Gershenson, David M.
Crawford, Jessica
Lu, Karen H.
GYNECOLOGIC ONCOLOGY, 2011, 120 (02) : 229 - 232
[35] Update on hereditary breast cancer
Smith K.L.
Robson M.E.
Current Oncology Reports, 2006, 8 (1) : 14 - 21
[36] Misperceptions of ovarian cancer risk in women at increased risk for hereditary ovarian cancer
Meiser, Bettina
Price, Melanie A.
Butow, Phyllis N.
Rahman, Belinda
Tucker, Kathy
Cheah, Benjamin
Bickerstaffe, Adrian
Hopper, John
Phillips, Kelly-Anne
FAMILIAL CANCER, 2014, 13 (02) : 153 - 162
[37] Legal Liabilities Associated with Hereditary Breast and Ovarian Cancers
Neff, Ennifer M. P.
Richardson, Gwyn
Phelps, John Y.
JOURNAL OF REPRODUCTIVE MEDICINE, 2020, 65 (7-8) : 227 - 230
[38] BARD1 Pathogenic Variants Are Associated with Triple-Negative Breast Cancer in a Spanish Hereditary Breast and Ovarian Cancer Cohort
Rofes, Paula
Del Valle, Jesus
Torres-Esquius, Sara
Feliubadalo, Lidia
Stradella, Agostina
Moreno-Cabrera, Jose Marcos
Lopez-Doriga, Adriana
Munte, Elisabet
De Cid, Rafael
Campos, Olga
Cuesta, Raquel
Teule, Alex
Grau, Elia
Sanz, Judit
Capella, Gabriel
Diez, Orland
Brunet, Joan
Balmana, Judith
Lazaro, Conxi
GENES, 2021, 12 (02) : 1 - 11
[39] Guidelines for Genetic Risk Assessment of Hereditary Breast and Ovarian Cancer: Early Disagreements and Low Utilization
Levy, Douglas E.
Garber, Judy E.
Shields, Alexandra E.
JOURNAL OF GENERAL INTERNAL MEDICINE, 2009, 24 (07) : 822 - 828
[40] Characterization of a novel germline PALB2 duplication in a hereditary breast and ovarian cancer family
Yang, Ciyu
Arnold, Angela G.
Trottier, Magan
Sonoda, Yukio
Abu-Rustum, Nadeem R.
Zivanovic, Oliver
Robson, Mark E.
Stadler, Zsofia K.
Walsh, Michael F.
Hyman, David M.
Offit, Kenneth
Zhang, Liying
BREAST CANCER RESEARCH AND TREATMENT, 2016, 160 (03) : 447 - 456

← 1 2 3 4 5 →